VivoSeq
Other

Ultrasound

0

Pipeline Programs

22

Active Trials

1

Companies Involved

Ultrasound is an early-stage landscape with 0 programs across 1 company. The most active players are Chiesi Poland Sp. z o.o..

Pipeline Metrics

Competitive Density

37/100

Pipeline Velocity

27/100

Mech. Concentration

N/A

Completion Rate

73/100

Attrition Rate

15/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

112

clinical trials

Completed48 · 43%
Unknown status24 · 21%
Terminated13 · 12%
Recruiting12 · 11%
Not yet recruiting6 · 5%
Withdrawn4 · 4%
Other5 · 4%

Trial Activity

112 trials

Study of Placental Vascularization Using Contrast Ultrasound
Recruiting··Phase 3·NCT06497959·30 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)